Autobio Total Revenue from 2010 to 2025

603658 Stock   40.10  0.31  0.77%   
Autobio Diagnostics' Total Revenue is increasing over the years with slightly volatile fluctuation. Overall, Total Revenue is expected to go to about 5.4 B this year. Total Revenue is the total amount of income generated by the sale of goods or services related to Autobio Diagnostics' primary operations. View All Fundamentals
 
Total Revenue  
First Reported
2015-03-31
Previous Quarter
1.1 B
Current Value
1.2 B
Quarterly Volatility
366.2 M
 
Yuan Drop
 
Covid
Check Autobio Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Autobio Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 29.6 M, Selling General Administrative of 373.1 M or Total Revenue of 5.4 B, as well as many indicators such as . Autobio financial statements analysis is a perfect complement when working with Autobio Diagnostics Valuation or Volatility modules.
  
This module can also supplement various Autobio Diagnostics Technical models . Check out the analysis of Autobio Diagnostics Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Autobio Stock

Autobio Diagnostics financial ratios help investors to determine whether Autobio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Autobio with respect to the benefits of owning Autobio Diagnostics security.